daunorubicin has been researched along with organophosphonates in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, NK; Vasanthakumar, G | 1 |
| Badiaga, S; Brouqui, P; Parola, P; Zandotti, C | 1 |
| Andreone, P; Bernardi, M; Calza, L; Chiodo, F; Giuliani, R; Manfredi, R; Tadolini, M; Trevisani, F; Verucchi, G; Zambruni, A | 1 |
| Tallman, M | 1 |
| Allen, SL; Damon, L; Egyed, M; Erba, HP; Horst, HA; Jang, JH; Lundberg, AS; Masszi, T; Mazzola, E; Neuberg, D; Pigneux, A; Powell, B; Rizzieri, D; Sekeres, MA; Selleslag, D; Solomon, SR; Stone, RM; Stuart, RK; Tallman, MS; Venugopal, P; Warzocha, K; Wetzler, M | 1 |
1 trial(s) available for daunorubicin and organophosphonates
| Article | Year |
|---|---|
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Induction Chemotherapy; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthalimides; Organophosphonates; Prospective Studies; Remission Induction; Time Factors; Treatment Outcome; Young Adult | 2015 |
4 other study(ies) available for daunorubicin and organophosphonates
| Article | Year |
|---|---|
Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside methylphosphonates.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Biological Transport; Cell Division; Cell Line; Daunorubicin; Drug Resistance; Gene Amplification; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Membrane Glycoproteins; Molecular Sequence Data; Molecular Weight; Neoplasm Proteins; Oligodeoxyribonucleotides; Organophosphonates; Transcription, Genetic; Tumor Cells, Cultured | 1989 |
Successful treatment of Kaposi's sarcoma with a combination of antiviral drug therapy and chemotherapy: two case reports.
Topics: Adult; Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Combination; Humans; Male; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Treatment Outcome | 1998 |
Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin.
Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Combination; Herpesvirus 8, Human; Humans; Immunocompromised Host; Liver Transplantation; Male; Middle Aged; Organophosphonates; Sarcoma, Kaposi; Viral Load; Viremia | 2005 |
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin | 2008 |